JPS6159637B2 - - Google Patents
Info
- Publication number
- JPS6159637B2 JPS6159637B2 JP54146642A JP14664279A JPS6159637B2 JP S6159637 B2 JPS6159637 B2 JP S6159637B2 JP 54146642 A JP54146642 A JP 54146642A JP 14664279 A JP14664279 A JP 14664279A JP S6159637 B2 JPS6159637 B2 JP S6159637B2
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- group
- chloroform
- acid
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003839 salts Chemical class 0.000 claims description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 9
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 238000004809 thin layer chromatography Methods 0.000 description 7
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 6
- 235000011114 ammonium hydroxide Nutrition 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 229930194936 Tylosin Natural products 0.000 description 5
- 239000004182 Tylosin Substances 0.000 description 5
- 230000008034 disappearance Effects 0.000 description 5
- -1 phosphoric acid Chemical class 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 5
- 229960004059 tylosin Drugs 0.000 description 5
- 235000019375 tylosin Nutrition 0.000 description 5
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 235000009518 sodium iodide Nutrition 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N p-toluenesulfonic acid Substances CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- NJUISRMVIKYYCN-UHFFFAOYSA-N acetic acid;chloroform;methanol;hydrate Chemical compound O.OC.CC(O)=O.ClC(Cl)Cl NJUISRMVIKYYCN-UHFFFAOYSA-N 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 238000007070 tosylation reaction Methods 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Description
本発明は、抗生物質タイロシンの新規誘導体に
関する。さらに詳しくは、本発明は、20−デオキ
ソデスマイコシン(20−デオキソ−4′−デマイカ
ロシルタイロシン)またはその塩である。
本発明の化合物は、新規化合物であつて、式
で表わされる。
上記の塩としては、医薬上許容できる塩であ
る。このような適当な塩としては、塩酸、硫酸、
リン酸などの無機酸との塩、酢酸、プロピオン
酸、酒石酸、クエン酸、コハク酸、リンゴ酸、ア
スパラギン酸、グルタミン酸などの有機酸との塩
が包含される。その他の非毒性塩も包含される。
上記の新規化合物〔〕は、原料であるタイロ
シンよりグラム陽性菌に対して極めて強い抗菌活
性を有することは、第1表より明らかであり、臨
床上優れた感染治療効果の期待される物質であ
る。また動物用治療薬剤、飼料添加剤としても有
用である。
The present invention relates to new derivatives of the antibiotic tylosin. More specifically, the present invention is 20-deoxodesmycosine (20-deoxo-4'-demycarosyltylosin) or a salt thereof. The compound of the present invention is a novel compound and has the formula It is expressed as The above salts are pharmaceutically acceptable salts. Such suitable salts include hydrochloric acid, sulfuric acid,
Included are salts with inorganic acids such as phosphoric acid, and salts with organic acids such as acetic acid, propionic acid, tartaric acid, citric acid, succinic acid, malic acid, aspartic acid, and glutamic acid. Other non-toxic salts are also included. It is clear from Table 1 that the above new compound [] has extremely stronger antibacterial activity against Gram-positive bacteria than the raw material tylosin, and is a substance that is expected to have clinically excellent infection treatment effects. . It is also useful as a therapeutic drug for animals and a feed additive.
【表】
上記目的化合物〔〕は、タイロシンの19位
CHO基をCH2OH基に還元し、このCH2OH基を
CH3基に変換し、得られた20−デオキソタイロシ
ンを稀酸で脱4′−マイカロシル化することにより
得られる。
19位CHO基のCH2OH基への還元は、9位の
CO基を還元しないような温和な条件で還元する
ような公知の還元方法により行なわれる。好適な
方法としては、NaBH4を用いる方法が挙げら
れ、好ましくは、Antimicrobial Agents and
Chemotherapy 1963,45(1964)に記載の方法
に準じて行なうのがよい。例えば7.5附近のPHを
有する含水メタノール中室温でNaBH4を反応さ
せればよい。反応時間はシリカゲルなどの薄層ク
ロマトグラフイーにより追跡できるので、タイロ
シンの消失を待つて適宜反応を終了すればよい。
得られた生成物は反応液を非親水性有機溶媒、例
えばクロロホルムで抽出することにより採取さ
れ、特に精製することなく次の反応に用いること
ができる。
19位CH2OH基をCH3基に変換するには、種々
の公知の方法によつて行なうことができる。例え
ばCH2OH基のOH基をトシル化し、次いでNaI+
Znでp−トルエンスルホン酸エステルを還元的
に脱離する方法によつて行なうことができる。
上記のトシル化は第3級有機アミン、例えばピ
リジンなどの脱酸剤および溶媒としての存在下p
−トルエンスルホニルハライドを反応させること
により行なわれる。反応の経過はシリカゲルなど
の薄層クロマトグラフイーにより追跡できるの
で、前記生成物、即ち20−ジヒドロ体の消失を待
つて適宜反応を終了すればよい。反応後を水中に
あけ、PH8〜10に調節して適当な非親水性有機溶
媒、例えばクロロホルムで抽出することにより20
位OH基がトシル化された生成物を採取すること
ができる。この生成物は、特に精製することな
く、次の反応に用いることができる。次に、この
p−トルエンスルホン酸エステルを還元的に脱離
するのであるが、この反応は適当な有機溶媒、例
えばエチレングリコールジメチルエーテル中で
NaIとZnの存在下加熱することにより行なわれ
る。上記の反応は、先ずCH2O−トシル基がCH2I
基に変換し、これがZnにより還元されてCH3に変
換するものである。反応の経過はシリカゲルなど
の薄層クロマトグラフイーにより追跡できるの
で、20位OH基がトシル化された生成物の消失を
待つて適宜反応を終了すればよい。このようにし
て得られた20−デオキソタイロシンを反応液から
採取するには、Znを別した反応液を水中にあ
け、非親水性有機溶液、例えばクロロホルムで抽
出することにより行なわれる。
次に、この20−デオキソタイロシンを脱4′−マ
イカロシル化するのであるが、この反応は稀酸、
例えば0.5N程度の塩酸で加水分解すればよい。
加水分解の時間は、シリカゲルなどの薄層クロマ
トグラフイーにより追跡できるので、20−デオキ
ソタイロシンの消失を待つて適宜反応を終了すれ
ばよい。
また、上記目的化合物〔〕は、次の別法によ
つても製造することができる。即ち、上記の製造
工程において、19位CHO基をCH2OH基に還元す
る前に、脱4′−マイカロシル化する方法である。
この場合の各工程における反応は、前記反応工程
と同様な条件で行なえばよい。
このようにして得られた20−デオキソデスマイ
コシンを反応液から採取するには、反応液をアン
モニア水などのアルカリで中和し、適当な非親水
性有機溶媒、例えばクロロホルムで抽出すること
により行なわれる。さらに精製を必要とする場合
には、シリカゲル、活性アルミナ、吸着樹脂など
の吸着剤を用いるカラムクロマトグラフイーによ
り精製することができる。
次に、実施例を挙げて本発明の製造例を具体的
に説明する。
尚、実施例中のRf値は、特記しない限り次の
担体および展開溶媒を用いる薄層クロマトグラフ
イー(TLC)により測定したものである。
担体;メルク社製シリカゲル60プレート
Art5721
展開溶媒;クロロホルムーメタノール−酢酸
水(80:7:7:1)
実施例 1
20−デオキソデスマイコシン
タイロシン5gを0.2Mリン酸緩衝液(PH7.5)
−メタノール(1:1)の混液150mlに溶かし、
これにNaBH4150mgを上記混液10mlに溶かした溶
液を加え、室温で1.5時間撹拌した後希アンモニ
ア水でPH9.5とし、反応液をクロロホルム100mlで
抽出する。クロロホルム層を水洗し、無水硫酸マ
グネシウムで乾燥後、減圧乾固して粗製の20−ジ
ヒドロタイロシン(UVλEtoH nax283nm、Rf=0.1
5)
を得る。
上記生成物をピリジン20mlに溶かし、これに塩
化トシル1.25gを加え、室温で16時間撹拌する。
反応液に濃アンモニア水5mlを加え、15分間撹拌
した後、水500ml中にあけ、クロロホルム100mlで
抽出する。クロロホルム層を水、希塩酸、水、希
アンモニア水の順に洗浄し、無水硫酸マグネシウ
ムで乾燥後、減圧乾固する。得られた粉末3.3g
をエチレングリコールジメチルエーテル30mlに溶
かし、これにヨウ化ナトリウム2.3g、亜鉛粉末
2gを加え、3時間加熱還流する。反応混合物を
過して亜鉛粉末を除去し、液に水100mlを加
え、希アンモニア水でPH9.5としクロロホルム100
mlで抽出する。クロロホルム層を水洗し、無水硫
酸マグネシウムで乾燥後、減圧乾固して粗製の20
−デオキソタイロシン(Rf=0.24)を得る。
上記生成物を0.5N塩酸50mlに溶かし、室温で
18時間撹拌する。反応液をアンモニア水でPH9.5
とし、クロロホルム100mlで抽出する。クロロホ
ルム層を水洗し、無水硫酸マグネシウムで乾燥
後、減圧乾固して20−デオキソデスマイコシンの
粗粉末2.2gを得る。この粉末をクロロホルム−
メタノール(15:1)を用いるシリカゲルカラム
クロマトグラフイーにより精製し、精製品780mg
を得る。
TLC;Rf=0.32
UVλEtoH nax283nm(ε=19700)Mass(m/
e);757(M+)、739,612,567,394,393,
377,359,358,190,174,173
NMR(100MHz、CDCl3);1.79(12−CH3)、
2.51(3′−N(CH3)2)、3.42および3.49
(OCH3)ppm、アルデヒド消失[Table] The above target compound [] is at position 19 of tylosin.
CHO group is reduced to CH 2 OH group, and this CH 2 OH group is
It can be obtained by converting it into a CH 3 group and de-4'-mycarosylating the obtained 20-deoxotylosine with a dilute acid. The reduction of the 19-position CHO group to the CH 2 OH group is performed by reducing the 9-position CHO group to the
The reduction is carried out using a known reduction method that performs reduction under mild conditions that do not reduce the CO group. Suitable methods include methods using NaBH4 , preferably Antimicrobial Agents and
Chemotherapy 1963, 45 (1964). For example, NaBH 4 may be reacted at room temperature in aqueous methanol having a pH of around 7.5. Since the reaction time can be monitored by thin layer chromatography using silica gel or the like, the reaction can be appropriately terminated after waiting for the disappearance of tylosin.
The obtained product is collected by extracting the reaction solution with a non-hydrophilic organic solvent, such as chloroform, and can be used in the next reaction without particular purification. The CH 2 OH group at position 19 can be converted to a CH 3 group by various known methods. For example, the OH group of CH 2 OH group is tosylated and then NaI+
This can be carried out by a method in which p-toluenesulfonic acid ester is reductively eliminated using Zn. The above tosylation is carried out in the presence of a tertiary organic amine, e.g. pyridine, as a deoxidizing agent and as a solvent.
- by reacting toluenesulfonyl halide. Since the progress of the reaction can be monitored by thin layer chromatography using silica gel or the like, the reaction can be appropriately terminated after waiting for the disappearance of the product, ie, the 20-dihydro compound. After the reaction, the mixture is poured into water, the pH is adjusted to 8 to 10, and the mixture is extracted with a suitable non-hydrophilic organic solvent such as chloroform.
A product in which the OH group is tosylated can be collected. This product can be used in the next reaction without particular purification. Next, this p-toluenesulfonic acid ester is removed reductively, and this reaction is carried out in a suitable organic solvent, such as ethylene glycol dimethyl ether.
This is done by heating in the presence of NaI and Zn. In the above reaction, the CH 2 O-tosyl group is first converted into CH 2 I
This is reduced by Zn and converted to CH 3 . Since the progress of the reaction can be monitored by thin layer chromatography using silica gel or the like, the reaction can be appropriately terminated after waiting for the disappearance of the product in which the OH group at the 20-position is tosylated. In order to collect the 20-deoxotylosine thus obtained from the reaction solution, the reaction solution from which Zn has been removed is poured into water and extracted with a non-hydrophilic organic solution, such as chloroform. Next, this 20-deoxotylosine is de-4'-mycarosylated, and this reaction is carried out using a dilute acid,
For example, it may be hydrolyzed with about 0.5N hydrochloric acid.
Since the hydrolysis time can be tracked by thin layer chromatography using silica gel or the like, the reaction can be appropriately terminated after waiting for the disappearance of 20-deoxotylosine. Moreover, the above-mentioned target compound [] can also be produced by the following alternative method. That is, in the above production process, the 19-position CHO group is de-4'-mycarosylated before being reduced to a CH 2 OH group.
The reaction in each step in this case may be carried out under the same conditions as in the reaction step. In order to collect the 20-deoxodesmycosine thus obtained from the reaction solution, the reaction solution is neutralized with an alkali such as aqueous ammonia and extracted with an appropriate non-hydrophilic organic solvent such as chloroform. This is done by If further purification is required, it can be purified by column chromatography using an adsorbent such as silica gel, activated alumina, or adsorption resin. Next, production examples of the present invention will be specifically explained with reference to Examples. The Rf values in the examples were measured by thin layer chromatography (TLC) using the following carrier and developing solvent, unless otherwise specified. Carrier: Merck silica gel 60 plate
Art5721 Developing solvent: Chloroform-methanol-acetic acid water (80:7:7:1) Example 1 20-deoxodesmycocin 5 g of tylosin in 0.2M phosphate buffer (PH7.5)
-Dissolved in 150 ml of methanol (1:1) mixture,
A solution of 150 mg of NaBH 4 dissolved in 10 ml of the above mixture was added to this, and after stirring at room temperature for 1.5 hours, the pH was adjusted to 9.5 with dilute ammonia water, and the reaction solution was extracted with 100 ml of chloroform. The chloroform layer was washed with water, dried over anhydrous magnesium sulfate, and dried under reduced pressure to obtain crude 20-dihydrotylosin (UVλ EtoH nax 283 nm, Rf=0.1
Five)
get. The above product was dissolved in 20 ml of pyridine, 1.25 g of tosyl chloride was added thereto, and the mixture was stirred at room temperature for 16 hours.
Add 5 ml of concentrated ammonia water to the reaction solution, stir for 15 minutes, pour into 500 ml of water, and extract with 100 ml of chloroform. The chloroform layer is washed successively with water, dilute hydrochloric acid, water, and dilute ammonia water, dried over anhydrous magnesium sulfate, and then dried under reduced pressure. 3.3g of powder obtained
was dissolved in 30 ml of ethylene glycol dimethyl ether, 2.3 g of sodium iodide and 2 g of zinc powder were added thereto, and the mixture was heated under reflux for 3 hours. The reaction mixture was filtered to remove zinc powder, 100 ml of water was added to the solution, the pH was adjusted to 9.5 with dilute ammonia water, and 100 ml of chloroform was added.
Extract in ml. The chloroform layer was washed with water, dried over anhydrous magnesium sulfate, and dried under reduced pressure to obtain crude 20
-Deoxotylosin (Rf=0.24) is obtained. Dissolve the above product in 50ml of 0.5N hydrochloric acid and let it stand at room temperature.
Stir for 18 hours. The reaction solution was adjusted to PH9.5 with aqueous ammonia.
and extract with 100 ml of chloroform. The chloroform layer was washed with water, dried over anhydrous magnesium sulfate, and dried under reduced pressure to obtain 2.2 g of crude powder of 20-deoxodesmycocin. This powder was mixed with chloroform.
Purified by silica gel column chromatography using methanol (15:1) to obtain 780 mg of purified product.
get. TLC; Rf=0.32 UVλ EtoH nax 283nm (ε=19700) Mass (m/
e); 757 (M + ), 739, 612, 567, 394, 393,
377, 359, 358, 190, 174, 173 NMR (100MHz, CDCl3 ); 1.79 (12- CH3 ),
2.51 (3'-N( CH3 ) 2 ), 3.42 and 3.49
(OCH 3 )ppm, aldehyde disappearance
Claims (1)
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14664279A JPS5671099A (en) | 1979-11-13 | 1979-11-13 | 20-deoxodesmycosin |
| NL8004922A NL8004922A (en) | 1979-09-19 | 1980-08-29 | DEFORMYLTYLOSINE DERIVATIVES. |
| DE19803033032 DE3033032A1 (en) | 1979-09-19 | 1980-09-02 | DEFORMYLTYLOSIN DERIVATIVES |
| US06/184,375 US4345069A (en) | 1979-09-19 | 1980-09-05 | Deformyltylosin derivatives |
| GB8029019A GB2058765B (en) | 1979-09-19 | 1980-09-09 | Deformyltylosin derivatives |
| FR8019987A FR2465747A1 (en) | 1979-09-19 | 1980-09-17 | DEFORMYLTYLOSINE DERIVATIVES USEFUL AS ANTIBIOTICS |
| CA000360427A CA1192542A (en) | 1979-09-19 | 1980-09-17 | Deformyltylosin derivatives |
| CH699780A CH645650A5 (en) | 1979-09-19 | 1980-09-18 | DEFORMYLTYLOSIN DERIVATIVES. |
| IT24738/80A IT1141057B (en) | 1979-09-19 | 1980-09-18 | DEFORMYLTYLOSINE DERIVATIVES AND THEIR PREPARATION |
| ES495214A ES495214A0 (en) | 1979-09-19 | 1980-09-19 | PROCEDURE FOR OBTAINING NEW DEFOR-MILTYLOSINO DERIVATIVES |
| ES503606A ES503606A0 (en) | 1979-09-19 | 1981-07-01 | PRODUCTION PROCEDURE OF 20-DEOXO-4-SEMICARORILTILOMIAO OF A SALT OF THE SAME. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14664279A JPS5671099A (en) | 1979-11-13 | 1979-11-13 | 20-deoxodesmycosin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5671099A JPS5671099A (en) | 1981-06-13 |
| JPS6159637B2 true JPS6159637B2 (en) | 1986-12-17 |
Family
ID=15412334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14664279A Granted JPS5671099A (en) | 1979-09-19 | 1979-11-13 | 20-deoxodesmycosin |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5671099A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4443436A (en) * | 1982-09-13 | 1984-04-17 | Eli Lilly And Company | C-20-Modified macrolide derivatives of the macrolide antibiotics tylosin, desmycosin, macrocin, and lactenocin |
| ZA841277B (en) * | 1983-02-28 | 1985-09-25 | Lilly Co Eli | C-20-and c-23-modified macrolide derivatives |
-
1979
- 1979-11-13 JP JP14664279A patent/JPS5671099A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5671099A (en) | 1981-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2751385B2 (en) | Process for producing erythromycin A oxime and its salt | |
| JPS6360031B2 (en) | ||
| JP3771128B2 (en) | Novel synthesis method of febrifugine and febrifugine compounds | |
| JPS6159637B2 (en) | ||
| JPS6312063B2 (en) | ||
| EP0381989B1 (en) | New 4'-epi-4'-amino anthracyclines | |
| FR2749585A1 (en) | NOVEL AROMATIC DERIVATIVES SUBSTITUTED BY RIBOSIS, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS | |
| EP0475071B1 (en) | 2-acyloxy-4-morpholinyl anthracycline | |
| JPS6319499B2 (en) | ||
| JP2000503666A (en) | Camptothecin isolated from Mappia foetida-backbone compounds and their use as synthons for novel pharmaceutical and therapeutic agents | |
| JPH0768163B2 (en) | Process for producing cyclopentenone derivative | |
| JP3285391B2 (en) | Method for producing 2-phenoxybenzoic acid | |
| JP3544727B2 (en) | Method for preparing 2,4,5-tribromopyrrole-3-carbonitrile | |
| JPS63307894A (en) | Ring-reduced macrolide antibiotic | |
| JPS59199693A (en) | Indolylglycylcephalosporin derivative | |
| JPH07103148B2 (en) | Anthracycline-macrolide complex | |
| DE69614030T2 (en) | Production and use of 7 - ((2-carbo-alkoxy-1-methylethenyl) amino) -3-hydroxymethyl-3-cephem-4-carboxylic acids | |
| JPS634826B2 (en) | ||
| JPH0510358B2 (en) | ||
| JPH02129199A (en) | Enol ethers of elaiophyrin and manufacture thereof | |
| JP2504934B2 (en) | 1,6,7-Triacylforskolin derivative | |
| JP2710052B2 (en) | Code factor-related compound, method for producing the same, and immunopotentiator containing the compound | |
| JPS6034985A (en) | 23-acylamino-23-deoxydemycinosyl-desmycosin derivative and its preparation | |
| JP2571939B2 (en) | Cyclopentenone derivatives and their production | |
| GB2201419A (en) | Anthracycline-oestrone derivatives |